Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Liam James 2025 Nov 11, 00:00

Wall Street Optimists: Strong Earnings to Fuel US Equity Growth in 2026

Liam James 2025 Nov 11, 00:00

Oil Price Stability: A Risk Assessment and Future Outlook

Ghko B 2025 Nov 10, 16:00

BTC/USD prediction: Why is BTC moving up today, can Bitcoin hit $110K?

Frances Wang 2025 Nov 10, 16:00

MNDY stock dropped 12% today: what happened to Monday.Com Ltd?

Ghko B 2025 Nov 10, 16:00

Shiba coin price prediction 2026: What will trigger $SHIB’s next rally?

Frances Wang 2025 Nov 10, 16:00

AI Stocks Analysis: Nebius (NBIS) Stock VS CRWV Stock, which is better?

Frances Wang 2025 Nov 10, 16:00

Gold Price Forecast: XAU/USD over $4,144, Is gold expected to go up more?

Frances Wang 2025 Nov 09, 16:00

Crypto trading basics: What is Ethereum? Does ETH have any future?

Frances Wang 2025 Nov 09, 16:00

A guide to crypto ETFs: Bitcoin ETF vs. Ethereum ETF, what’s the difference?

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Latest news

Show more
Sophia Claire 2025 Nov 11, 21:00

Selig CFTC Nomination Faces Senate Hearing Amid Regulatory Shifts

Noah Lee 2025 Nov 11, 20:30

Crypto Industry Transparency: Post-FTX Efforts and Compensation Challenges

Liam James 2025 Nov 11, 19:50

John Deaton Eyes 2026 US Senate Run: Will Crypto Be a Key Issue?

Liam James 2025 Nov 11, 19:10

ClearToken Secures FCA Approval to Launch Crypto Settlement System in the UK

Liam James 2025 Nov 11, 18:30

VCI Global Invests $100M in OOB Tokens, Eyes Digital Treasury Control

Ava Grace 2025 Nov 11, 17:30

US Government Nears Reopening as Senate Passes Funding Bill

Noah Lee 2025 Nov 11, 17:20

PrizePicks Partners with Polymarket to Enter Prediction Markets

Noah Lee 2025 Nov 11, 14:50

Ideosphere Aims to Channel Crypto Prediction Markets into Funding Scientific Research

Info

Spread

1.18

Spread (%)

0.6107 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

453935300608

Shares Outstanding

2409295102

Earnings Date (Next)

2001-06-13

Div Yield

2025-12-09

Ex-Dividend Date

2025-11-25

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0276

EPS

10.34

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 10, 16:00

What are the different types of gold: How to invest in gold?

Ghko B 2025 Nov 10, 16:00

How to invest in gold now: what’s the best way to buy and sell gold?

Ghko B 2025 Nov 09, 16:00

Commodity trading: What is platinum, is it better to buy gold or platinum?

Trustpilot